PL-461, identified by its CAS number 874339-65-8, is a chemical compound that has garnered attention in various research contexts, particularly in the field of medicinal chemistry. While specific characteristics such as its molecular structure, physical properties, and biological activity may vary, compounds like PL-461 are typically evaluated for their potential therapeutic applications. They may exhibit unique solubility profiles, stability under various conditions, and specific interactions with biological targets. The compound's efficacy, safety, and mechanism of action would be of particular interest in pharmacological studies. Additionally, its synthesis and characterization would involve standard organic chemistry techniques, including spectroscopic methods for structural elucidation. As with many research chemicals, detailed information may be limited to scientific literature or proprietary databases, emphasizing the importance of consulting peer-reviewed studies for comprehensive insights into its properties and applications.

PPL-100, also known as PL-461 and PL-462, is a HIV protease inhibitor potentially for the treatment of HIV infection.

PL-461

874339-65-8: PL-461, identified by its CAS number 874339-65-8, is a chemical compound that has garnered attention in various research contexts, particularly in the field of medicinal chemistry. While specific characteristics such as its molecular structure, physical properties, and biological activity may vary, compounds like PL-461 are typically evaluated for their potential therapeutic applications. They may exhibit unique solubility profiles, stability under various conditions, and specific interactions with biological targets. The compound's efficacy, safety, and mechanism of action would be of particular interest in pharmacological studies. Additionally, its synthesis and characterization would involve standard organic chemistry techniques, including spectroscopic methods for structural elucidation. As with many research chemicals, detailed information may be limited to scientific literature or proprietary databases, emphasizing the importance of consulting peer-reviewed studies for comprehensive insights into its properties and applications.

PPL-100, a HIV protease inhibitor, is used potentially for the treatment of HIV infection.

CAS 874339-65-8

PL-461

PPL-100

Ref: TM-T28442